$EXAS
EXACT SCIENCES CORP

2020 Q3 Form 10-Q Financial Statement

#000112414020000064 Filed on October 27, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $408.4M $218.8M $199.9M
YoY Change 86.63% 84.97% 94.25%
Cost Of Revenue $95.06M $52.34M $51.14M
YoY Change 81.64% 76.3% 92.59%
Gross Profit $292.7M $166.0M $148.3M
YoY Change 76.3% 88.11% 95.13%
Gross Profit Margin 71.69% 75.89% 74.2%
Selling, General & Admin $252.1M $166.7M $151.9M
YoY Change 51.18% 49.5% 61.68%
% of Gross Profit 86.11% 100.41% 102.43%
Research & Development $31.47M $34.71M $29.97M
YoY Change -9.34% 99.51% 106.97%
% of Gross Profit 10.75% 20.91% 20.21%
Depreciation & Amortization $19.70M $8.400M $7.100M
YoY Change 134.52% 37.7% 39.22%
% of Gross Profit 6.73% 5.06% 4.79%
Operating Expenses $496.1M $201.8M $182.2M
YoY Change 145.86% 56.18% 67.61%
Operating Profit -$203.3M -$35.73M -$33.90M
YoY Change 469.15% -12.7% 3.67%
Interest Expense $23.58M $13.21M $12.71M
YoY Change 78.53% 23.4% 47.76%
% of Operating Profit
Other Income/Expense, Net -$1.955M -$4.116M -$5.043M
YoY Change -52.5% -6.71% 36.81%
Pretax Income -$205.3M -$39.84M -$38.95M
YoY Change 415.26% -12.12% 7.03%
Income Tax -$2.752M $683.0K -$443.0K
% Of Pretax Income
Net Earnings -$202.5M -$40.53M -$38.50M
YoY Change 399.79% -10.67% 5.81%
Net Earnings / Revenue -49.6% -18.52% -19.26%
Basic Earnings Per Share -$1.35 -$0.31 -$0.30
Diluted Earnings Per Share -$1.35 -$0.31 -$0.30
COMMON SHARES
Basic Shares Outstanding 150.2M shares 129.6M shares 129.2M shares
Diluted Shares Outstanding 150.2M shares 129.6M shares 129.2M shares

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.283B $1.161B $1.239B
YoY Change 10.56% -2.08% 1.41%
Cash & Equivalents $806.7M $1.034B $205.1M
Short-Term Investments $476.3M $126.2M $1.034B
Other Short-Term Assets $36.60M $23.60M $23.70M
YoY Change 55.08% -0.84% 43.64%
Inventory $80.43M $53.67M $47.78M
Prepaid Expenses
Receivables $206.6M $82.20M $63.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.607B $1.320B $1.375B
YoY Change 21.72% 2.36% 4.92%
LONG-TERM ASSETS
Property, Plant & Equipment $456.5M $370.5M $335.5M
YoY Change 23.19% 96.57% 138.79%
Goodwill $1.238B $17.28M $17.28M
YoY Change 7062.87%
Intangibles $871.7M
YoY Change
Long-Term Investments
YoY Change
Other Assets $52.12M $24.37M $26.60M
YoY Change 113.84% 170.81% 202.3%
Total Long-Term Assets $2.748B $439.3M $407.1M
YoY Change 525.5% 99.68% 136.16%
TOTAL ASSETS
Total Short-Term Assets $1.607B $1.320B $1.375B
Total Long-Term Assets $2.748B $439.3M $407.1M
Total Assets $4.354B $1.759B $1.782B
YoY Change 147.51% 16.54% 20.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.06M $19.16M $19.90M
YoY Change 36.03% -41.41% 80.87%
Accrued Expenses $182.9M $134.8M $151.0M
YoY Change 35.68% 90.44% 135.22%
Deferred Revenue $22.40M $700.0K $700.0K
YoY Change 3100.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.300M $316.2M $312.0M
YoY Change -99.59% 6682.61%
Total Short-Term Liabilities $252.8M $480.7M $492.5M
YoY Change -47.4% 350.51% 493.33%
LONG-TERM LIABILITIES
Long-Term Debt $1.578B $500.8M $494.0M
YoY Change 215.02% -25.63% -23.86%
Other Long-Term Liabilities $62.82M $29.51M $29.92M
YoY Change 112.87% 132.37% 360.37%
Total Long-Term Liabilities $62.82M $29.51M $29.92M
YoY Change 112.87% -95.7% -95.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $252.8M $480.7M $492.5M
Total Long-Term Liabilities $62.82M $29.51M $29.92M
Total Liabilities $2.017B $1.011B $1.016B
YoY Change 99.54% 27.52% 37.67%
SHAREHOLDERS EQUITY
Retained Earnings -$1.531B -$1.198B -$1.157B
YoY Change 27.87%
Common Stock $3.867B $1.946B $1.921B
YoY Change 98.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.731B $748.3M $765.5M
YoY Change
Total Liabilities & Shareholders Equity $4.354B $1.759B $1.782B
YoY Change 147.51% 16.54% 20.18%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$202.5M -$40.53M -$38.50M
YoY Change 399.79% -10.67% 5.81%
Depreciation, Depletion And Amortization $19.70M $8.400M $7.100M
YoY Change 134.52% 37.7% 39.22%
Cash From Operating Activities $81.80M -$29.10M $17.00M
YoY Change -381.1% 609.76% -166.67%
INVESTING ACTIVITIES
Capital Expenditures -$14.00M -$51.70M -$69.00M
YoY Change -72.92% -3.54% 137.11%
Acquisitions
YoY Change
Other Investing Activities $30.90M $909.1M -$33.50M
YoY Change -96.6% -3679.13% -67.06%
Cash From Investing Activities $16.80M $857.4M -$102.5M
YoY Change -98.04% -1185.32% -21.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.200M 1.000M 5.500M
YoY Change 320.0% -94.76% -97.64%
NET CHANGE
Cash From Operating Activities 81.80M -29.10M 17.00M
Cash From Investing Activities 16.80M 857.4M -102.5M
Cash From Financing Activities 4.200M 1.000M 5.500M
Net Change In Cash 102.8M 829.3M -80.00M
YoY Change -87.6% -1395.78% -203.9%
FREE CASH FLOW
Cash From Operating Activities $81.80M -$29.10M $17.00M
Capital Expenditures -$14.00M -$51.70M -$69.00M
Free Cash Flow $95.80M $22.60M $86.00M
YoY Change 323.89% -54.34% 2288.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001124140
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssets
CY2020Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
dei Entity Registrant Name
EntityRegistrantName
EXACT SCIENCES CORPORATION
dei Entity File Number
EntityFileNumber
001-35092
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
02-0478229
dei Entity Address Address Line1
EntityAddressAddressLine1
5505 Endeavor Lane
dei Entity Address City Or Town
EntityAddressCityOrTown
Madison
dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
53719
dei City Area Code
CityAreaCode
608
dei Local Phone Number
LocalPhoneNumber
535-8815
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
EXAS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
150424035 shares
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
806678000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177254000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
476324000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
146401000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206606000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130667000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
80427000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
61724000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36592000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
40913000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1606627000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
556959000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
456455000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455325000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
129837000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126444000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
1237672000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1203197000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
871660000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1143550000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52119000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20293000 USD
CY2020Q3 us-gaap Assets
Assets
4354370000 USD
CY2019Q4 us-gaap Assets
Assets
3505768000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
26061000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25973000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
182945000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
193329000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10746000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7891000 USD
CY2020Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1319000 USD
CY2019Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
834000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
31761000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8467000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
252832000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
236494000 USD
CY2020Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1554967000 USD
CY2019Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
803605000 USD
CY2020Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
22643000 USD
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
24032000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
62821000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34911000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
124007000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
118665000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
2017270000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1217707000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100000 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150373486 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150373486 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
147625696 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
147625696 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
1505000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1477000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3865990000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3406440000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1084000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1531479000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1119756000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2337100000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2288061000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4354370000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3505768000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
408363000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
218805000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1025052000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
580718000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
95061000 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
52335000 USD
us-gaap Cost Of Revenue
CostOfRevenue
254559000 USD
us-gaap Cost Of Revenue
CostOfRevenue
146301000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31471000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34714000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23430000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107653000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96471000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
136481000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
86196000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
423092000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
265325000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
115589000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80538000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
336265000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
208067000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
748000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70199000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2256000 USD
CY2020Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
209666000 USD
CY2019Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
209666000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
611698000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
254531000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1401434000 USD
us-gaap Costs And Expenses
CostsAndExpenses
718420000 USD
CY2020Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 USD
CY2019Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 USD
us-gaap Other Operating Income
OtherOperatingIncome
23665000 USD
us-gaap Other Operating Income
OtherOperatingIncome
0 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-203335000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35726000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-352717000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-137702000 USD
CY2020Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2523000 USD
CY2019Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
9093000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
5532000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
23417000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-23582000 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13209000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-71647000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-47911000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-21059000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4116000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-66115000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24494000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-224394000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39842000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-418832000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-162196000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4510000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
683000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7109000 USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-230000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-219884000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-40525000 USD
us-gaap Net Income Loss
NetIncomeLoss
-411723000 USD
us-gaap Net Income Loss
NetIncomeLoss
-161966000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.46
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.76
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.26
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
150155000 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
129567000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
149346000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
128344000 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-219884000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-40525000 USD
us-gaap Net Income Loss
NetIncomeLoss
-411723000 USD
us-gaap Net Income Loss
NetIncomeLoss
-161966000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
680941000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
268390000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
182435000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-300768000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3650000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
7409000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16166000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-82939000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1656000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
776940000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-405000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-2697000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1159000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1431000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
25000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
0 USD
CY2020Q3 exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-220289000 USD
CY2019Q3 exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-43222000 USD
exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-410539000 USD
exas Comprehensive Income Loss Before Tax
ComprehensiveIncomeLossBeforeTax
-160535000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-643000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
341000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-220289000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42579000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-410539000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-160876000 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2288061000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
346641000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-64199000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4300000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
12007000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29560000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
28597000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-105697000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1617000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-22000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1348000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20143000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1391000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
41476000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2537653000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6638000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
40039000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9799000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-86142000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3206000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2511193000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4470000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
250000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-219884000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-405000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2337100000 USD
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-38502000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4137000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1488000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
765532000 USD
CY2019Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
26 shares
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
24348000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7954000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
409000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
409000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-40525000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2054000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
748284000 USD
us-gaap Profit Loss
ProfitLoss
-411723000 USD
us-gaap Profit Loss
ProfitLoss
-161966000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53345000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21920000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-930000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-880000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1183000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7976000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-341000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
111075000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
60657000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
30778000 USD
exas Amortization Of Deferred Financing Costs Credits And Other Liabilities
AmortizationOfDeferredFinancingCostsCreditsAndOtherLiabilities
-3614000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10558000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
55222000 USD
exas Amortization Of Deferred Financing Costs Credits And Other Liabilities
AmortizationOfDeferredFinancingCostsCreditsAndOtherLiabilities
-2421000 USD
exas Increase Decrease In Amortization Of Premium On Short Term Investments
IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments
1040000 USD
exas Increase Decrease In Amortization Of Premium On Short Term Investments
IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments
-6229000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70199000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2256000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
209666000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
11041000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
2681000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
73642000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36871000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18472000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14525000 USD
exas Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-6135000 USD
exas Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2628000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7608000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16279000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-34959000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
7382000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25078000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-86354000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
890012000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
604129000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
559907000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1449330000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47782000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
130970000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6658000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
10610000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
244000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
530000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-395399000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
713701000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1125547000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
729477000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
15408000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6389000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
9799000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4137000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
150054000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
493356000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-938000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-90000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
999762000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
246557000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
629441000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
873904000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177528000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160430000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
806969000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1034334000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
7209000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
16933000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
1159000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
1431000 USD
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
136559 shares
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
86535 shares
exas Issuance Of Stock To Fund Matching Contributions
IssuanceOfStockToFundMatchingContributions
12007000 USD
exas Issuance Of Stock To Fund Matching Contributions
IssuanceOfStockToFundMatchingContributions
7409000 USD
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
2159017 shares
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
182435000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company’s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of convertible notes, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company’s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2019 Form 10-K.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The spread of the coronavirus (“COVID-19”) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The COVID-19 outbreak, which the World Health Organization has classified as a pandemic, has prompted governments and regulatory bodies throughout the world to enact broad precautionary measures, including “stay-at-home” orders, restrictions on the performance of “non-essential” services, public gatherings and travel. Health systems, including key markets where the Company operates, have been, or may be, overwhelmed with high volumes of patients suffering from COVID-19. Even in areas where “stay-at-home” restrictions have been lifted and the number of cases of COVID-19 has declined, many individuals remain cautious about resuming activities such as preventive-care medical visits. Medical practices continue to be cautious about allowing individuals, such as sales representatives, into their offices. Many individuals continue to work from home rather from an office setting. The Company cannot forecast when the COVID-19 pandemic will end or the extent to which practices that have emerged during the pandemic will continue once it subsides.</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The extent to which COVID-19 impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, access to capital markets, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September 30, 2020 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company’s allowance for doubtful accounts and credit losses, equity investments, software, and the carrying value of the goodwill and other long-lived assets. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Despite the Company’s efforts, the ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</span></div>
exas Coronavirus Aid Relief And Economic Securities Cares Act Funds Received
CoronavirusAidReliefAndEconomicSecuritiesCARESActFundsReceived
23700000 USD
exas Debt Instrument Convertible Equity Component Consideration Settled
DebtInstrumentConvertibleEquityComponentConsiderationSettled
-64199000 USD
exas Debt Instrument Convertible Equity Component Consideration Settled
DebtInstrumentConvertibleEquityComponentConsiderationSettled
-300768000 USD
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
386293 shares
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
28847000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
us-gaap Interest Paid Net
InterestPaidNet
9239000 USD
us-gaap Interest Paid Net
InterestPaidNet
4944000 USD
exas Coronavirus Aid Relief And Economic Securities Cares Act Funds Received
CoronavirusAidReliefAndEconomicSecuritiesCARESActFundsReceived
23700000 USD
exas Minimum Contractual Term Of Certain Current Investments Which Can Be Liquidated
MinimumContractualTermOfCertainCurrentInvestmentsWhichCanBeLiquidated
P1Y
CY2020Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
33842000 USD
CY2019Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
24958000 USD
CY2020Q3 exas Inventory Finished Semi Finished Goods
InventoryFinishedSemiFinishedGoods
46585000 USD
CY2019Q4 exas Inventory Finished Semi Finished Goods
InventoryFinishedSemiFinishedGoods
36766000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
80427000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
61724000 USD
CY2020Q3 exas Number Of Stages Of Software Development
NumberOfStagesOfSoftwareDevelopment
3 stagesInSoftwareDevelopment
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2019Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
exas Lessee Operating Lease Option To Terminate Period
LesseeOperatingLeaseOptionToTerminatePeriod
P1Y
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27549000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18298000 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reclassifications</span></div><div style="text-indent:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements including the amortization of acquired intangible assets, which is now presented as a separate line item on the Company's condensed consolidated statements of operations and was previously included in cost of sales, research and development, and general and administrative expenses. Due to these reclassifications, the Company is no longer presenting gross margin on the Company's condensed consolidated statements of operations.</span></div>
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
408363000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
218805000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1025052000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
580718000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
22400000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
600000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
806969000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
177528000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1418000 USD
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1716000 USD
CY2020Q3 us-gaap Marketable Securities
MarketableSecurities
476324000 USD
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
146401000 USD
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1283293000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
323929000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
758821000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
759336000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
823799000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1084000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
824883000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
175082000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
87000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
175007000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
64978000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
65547000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
74990000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
74990000 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
0 USD
CY2020Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
1000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
3100000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
100000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
3300000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
33000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
300000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 USD
CY2019Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
586216000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
532956000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
129761000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
77631000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
456455000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20411000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455325000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
19500000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
8400000 USD
us-gaap Depreciation
Depreciation
52900000 USD
us-gaap Depreciation
Depreciation
21800000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
959895000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
88441000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
871454000 USD
CY2020Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
960101000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
88441000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
871660000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
963690000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20411000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
943279000 USD
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1163961000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
92421000 USD
CY2020Q3 exas Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
476426000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1143550000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
23357000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
93322000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
93116000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
92812000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
871454000 USD
CY2019Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018Q4 us-gaap Goodwill
Goodwill
17279000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1203197000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
1237672000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2879000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
exas Business Combination Contingent Consideration Gain Loss Recognized
BusinessCombinationContingentConsiderationGainLossRecognized
0 USD
us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
241000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2638000 USD
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2019Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
17000000.0 shares
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
400000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
400000 shares
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
1159000 USD
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-25000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
1184000 USD
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
815000 USD
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-616000 USD
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
1431000 USD
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
341000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41500000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24300000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
111100000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60700000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
0 USD
CY2020Q3 exas Number Of Employees Performance Based Equity Awards Impacted By Change In Operational Milestones
NumberOfEmployeesPerformanceBasedEquityAwardsImpactedByChangeInOperationalMilestones
36 employees
exas Number Of Employees Performance Based Equity Awards Impacted By Change In Operational Milestones
NumberOfEmployeesPerformanceBasedEquityAwardsImpactedByChangeInOperationalMilestones
36 employees
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
2400000 USD
us-gaap Regulatory Liability Amortization Period
RegulatoryLiabilityAmortizationPeriod
P2Y
us-gaap Operating Lease Payments
OperatingLeasePayments
12827000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
3744000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
125000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
620000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10700000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13662000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20147000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
17420000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
129800000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126400000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
134700000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
124000000.0 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
126600000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7900000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
118700000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0683
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y11M12D
CY2020Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
16900000 USD
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
300000 USD
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
16900000 USD
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4000000.0 USD
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10600000 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
12900000 USD
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
200000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
32000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
200000 USD
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0587
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M9D
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8000000.0 USD
CY2020Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
101.95
CY2020Q3 exas Debt Instrument Convertible If Converted Principal Amount
DebtInstrumentConvertibleIfConvertedPrincipalAmount
110800000 USD
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1123000 USD
CY2019Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
658000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3084000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1989000 USD
CY2020Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19461000 USD
CY2019Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
10322000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
52138000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
28789000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7954000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10558000 USD
CY2020Q3 exas Coupon Interest Expense
CouponInterestExpense
2567000 USD
CY2019Q3 exas Coupon Interest Expense
CouponInterestExpense
1739000 USD
exas Coupon Interest Expense
CouponInterestExpense
7065000 USD
exas Coupon Interest Expense
CouponInterestExpense
5585000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
23151000 USD
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
12719000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
70241000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
46921000 USD
CY2020Q3 us-gaap Interest Expense Other
InterestExpenseOther
431000 USD
CY2019Q3 us-gaap Interest Expense Other
InterestExpenseOther
490000 USD
us-gaap Interest Expense Other
InterestExpenseOther
1406000 USD
us-gaap Interest Expense Other
InterestExpenseOther
990000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
23582000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
13209000 USD
us-gaap Interest Expense
InterestExpense
71647000 USD
us-gaap Interest Expense
InterestExpense
47911000 USD
CY2020Q1 us-gaap Business Combination Consideration Transferred Including Equity Interest In Acquiree Held Prior To Combination1
BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
8400000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
408363000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
218805000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1025052000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
580718000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4500000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
21500000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14400000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10200000 USD

Files In Submission

Name View Source Status
0001124140-20-000064-index-headers.html Edgar Link pending
0001124140-20-000064-index.html Edgar Link pending
0001124140-20-000064.txt Edgar Link pending
0001124140-20-000064-xbrl.zip Edgar Link pending
a0930202010-qexhibit101.htm Edgar Link pending
a0930202010qexhibit311.htm Edgar Link pending
a0930202010qexhibit312.htm Edgar Link pending
a0930202010qexhibit321.htm Edgar Link pending
exas-20200930.htm Edgar Link pending
exas-20200930.xsd Edgar Link pending
exas-20200930_cal.xml Edgar Link unprocessable
exas-20200930_def.xml Edgar Link unprocessable
exas-20200930_htm.xml Edgar Link completed
exas-20200930_lab.xml Edgar Link unprocessable
exas-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending